rhinoplasty.cc
Menu

Journal archive · 2025

APS Aesthetic Plastic Surgery · 2025

Hyaluronidase: A New and Powerful Ally for Post-Rhinoplasty Fibrosis

Nele G, Tambasco D, Cavaliere A.

What this paper says

The authors propose combining triamcinolone acetonide with hyaluronidase to treat scar tissue build up after rhinoplasty, particularly in patients with thick oily skin; the abstract reports no patient data.

Overview

Rhinoplasty results depend on patient selection, technique, surgical skill and how the patient heals. Several surgical measures aim to reduce the risk of scar tissue forming: closing the empty space beneath the skin, dissecting in the deeper planes beneath the cartilage and bone coverings, and preserving or reconstructing the nasal ligaments. The authors state these are sometimes not enough, especially in thick sebaceous skin, and propose a drug combination instead.

Sections of note

  • Article type: brief technique proposal. Level of evidence V, the lowest grade.
  • Surgical measures listed for reducing fibrosis risk: closing dead spaces, subperichondrial and subperiosteal dissection, and preserving or reconstructing nasal ligaments.
  • Population identified as at highest risk: patients with thick and sebaceous skin.
  • Proposed treatment: a combination of triamcinolone acetonide and hyaluronidase.
  • No patient numbers, doses, injection intervals, outcomes or complication rates appear in the abstract.
  • No comparison against steroid injection alone, the current standard, is reported.

What it means for a patient

  • Scar tissue under the skin after rhinoplasty can thicken the nose and blunt its definition, most often in thick oily skin.
  • Steroid injection is already used for this; the addition proposed here is an enzyme that breaks down one component of the scar matrix.
  • The abstract carries no findings. It gives no doses, no results and no evidence the combination works better than steroid alone.
  • Level V is the lowest evidence grade, reflecting a proposal rather than a study.

Why this paper matters

Prolonged swelling and scar formation in thick skinned patients are among the least solved problems in rhinoplasty, and surgical measures alone often fall short. Non-surgical adjuncts are the obvious next line. Whether adding hyaluronidase to steroid changes outcomes remains entirely untested here.

Terms

  • Fibrosis: formation of excess scar tissue.
  • Hyaluronidase: an enzyme that breaks down hyaluronic acid in tissue.
  • Triamcinolone acetonide: an injectable steroid used to reduce inflammation and scarring.
  • Sebaceous skin: skin with abundant oil glands, typically thicker.
  • Dead space: an empty pocket under lifted tissue where fluid can collect.
  • Subperichondrial and subperiosteal: dissection planes beneath the coverings of cartilage and bone.

Summary written by rhinoplasty.cc from the abstract, 2026-09-09; not medical advice. The authors' own abstract follows.

Abstract

Rhinoplasty outcome may depend on different factors: patient's selection, technique, surgeons' skills and patient's healing. Different surgical maneuvers can be performed in order to reduce post-operative risk of fibrosis such as dead spaces' closure, sub-perichondral and subperiosteal dissection and nasal ligaments preservation or reconstruction. However, in some patients, especially the ones with thick and sebaceous skin, these maneuvers may not be enough. Here we propose a new alternative to treat post-rhinoplasty fibrosis using a combination of Triamcinolone Acetonide and Hyaluronidase. LEVEL OF EVIDENCE V: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

Abstract as indexed by PubMed; the article is open access (PubMed Central).

Citation

PubMed
Journal
Aesthetic Plastic Surgery
Year
2025
Authors
3
Type
Letter
Access
Open access
On this site
Summary and abstract

Start here

This paper sits outside the 16 topic groups; the archive holds every paper by journal and year.

Related papers

Same journal, 2025.

  1. APS
    2025PMID 38977456Summary
  2. APS
    2025PMID 38926251Full text
  3. APS
    2025PMID 39572464Summary
  4. APS
    2025PMID 40055225
  5. APS
    2025PMID 39322837Summary
  6. APS
    2025PMID 39187588Summary
  7. APS
    2025PMID 39179657Summary
  8. APS
    2025PMID 40389738Summary